Inorganic nanoparticles are widely investigated as drug delivery systems. In particular micro and nano‐particles of CaCO 3 offer smart features for different biomaterials applications. In this work we exploit the phospholipids coating of nano‐CaCO 3 . We prepare modified phospholipids through a chemo‐enzymatic approach using Phospholipase D to efficiently transform the most abundant natural phospholipids in two products, sn‐glycero‐3‐phosphocholine (GPC) and sn‐glycero‐3‐phosphoserine (GPS). We have investigated and modified the Spray Drier process to obtain nano‐crystals with specific phase, surface ζ‐potential and morphology. The intracellular localization of coated nano‐crystals was achieved by ultrastructural microscopy analysis. The synthetized phospholipids, GPC and GPS, improve nano‐CaCO 3 proprieties and promote a specific targeting as opposed to a widespread and nonspecific localization in the cell.
No takes yet. Share an insight, caveat, or question.
Baldassarre et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: